INEFAM:MEX® / INEFAM:LATAM®

México & LATAM

Pharmaceutical Public Sector
Audit Tools.

INEFAM® is the biggest LATAM Specialized MarketAccess

public sector business think tank Training.
for the following target markets:

• Pharmaceuticals.
Public Sector Business
• Medical Devices.
Consulting.
• Healing Material.

Unions & Industrial Associations

Public Policies Guidance.

1
About Us.

2
INEFAM International Presence.

INEFAM has established branches with

presence in:
• Mexico • São Paulo.
City.

• Instituto de Investigación e Innovación Farmacéutica, A.C. • Instituto Farmacêutico do Brasil Ltda.

• Instituto Farmacéutico, S. de R.L. de C.V.
• Negocios de Innovación Farmacéutica, S.C. Established: 2019.

Established: 2006
INEFAM: What do we do?

México & LATAM Pharmaceutical Public Specialized Market Access

Sector Audit Tools. Training.

• You can benefit from our 34 different public

• Either online or inhouse, we
sector market audit tools to answer all your
have already developed
questions regarding the LATAM pharma
market access training
market.
material & content.
• For the specific case of México, we cover the
• We can adjust the curriculae
following market groups: Drugs, Medical
to fit your training needs.
Devices and Healing Material.

Unions & Industrial Associations Public

Public Sector Business
Policies Guidance.
Consulting.

• Half a dozen industrial associations are

• Whether you need a business
already working with INEFAM to help
guidance to help you grow
them protect the strategic position of
your business in LATAM, or to
the pharma industry in the country.
develop your KPI’s or even
• Via primary research, or just gathering
help you with a full business
real-time data, we make sure your
landing, we are your one stop
associates are up-to-date with the opps
shop.
& threats of the macro environment.
INEFAM: For whom we do what we do?

W E P ROV I D E AC T I O N ABL E A N D U S E F U L B U S I N ES S I N S I GH TS
TO O U R C L I E N T S I N D I F F E R E NT CO U N T R I ES
BI & MKT Support. You can use our market audit tools to provide more specific and
actual data of business trends, threats and opportunities.
General Managers can look for INEFAM’s advise in order to obtain a very
precise insight of the way your company is heading to. You can also ask
INEFAM’s directive personnel to become a part of your counsel or
administration board. If you are in Marketing, you can obtain from us many insights and relevant data
to present a more reliable and concrete marketing plan for your brand that sells to
the public sector.
Commercial Directors can obtain from our audit tools
all the knowledge you need to accomplish the 120% of
your sales quota to the public sector.
Business Development Managers/Directors often worry a lot to obtain market
values in the public sector in LATAM. Well, we are your one stop shop for that!

SFE. Using our market audit tools, you can

design, develop and track all the external
Public Affairs. You can ask INEFAM directive KPI’s you need in order to guarantee the
board to help you in public affairs or lobbying full accomplishment of the business
to protect your interests or market access objectives.
initiatives.

Industrial Unions &

Associations look for advise
The Regulatory Affairs from INEFAM directors to
Directors can obtain our help protect their associate’s
guidance and advise on how best interest.
to enter LATAM markets
covering all the regulatory
requirements in each
country of LATAM Market Access and/or Pharmacoeconomy. The health economics
analysis are more powerful as long as more real data is included. INEFAM
provides market values to fortify your cost benefit analysis.
 INEFAM:LATAM® Brief Résumé:

THE MEXICO PHARMACEUTICAL INSTITUTE IS THE BIGGEST CERTIFIED

CONSULTANCY AND RESEARCH CENTER FOR PUBLIC SECTOR WITH
STRONG ALLIANCES IN MÉXICO, BRAZIL & EUROPE.
• INEFAM® is the biggest and most renowned public institutional sector consulting firm for 7 LATAM
& Brazillian markets.
• INEFAM is the biggest business intelligence on public sectors of México, Brazil, Colombia,
Guatemala, Panamá, Costa Rica & República Dominicana, with over 150 million of records in the
(CANIFARMA Reg. No. Z7007)
big data.
• 12 yrs in the market, founded in 2006.
• 109 pharma industry clients during 2019.
• Over 250 successfull consulting projectsdelivered.
• Has signed contracts with over 150 pharmaceutical and distributioncompanies.
• INEFAM® is a certified research center for CONACyT (mexican science and technology national
center).
• We are also effective members of the most important middle size pharma companiesassociation
in Europe, EUROPHARM SMC.
• INEFAM DO BRASIL Ltda is affiliated to SINDUSFARMA inBrazil.
• Specialized health sector data provider for CANIFARMA, AMIIF, ANAFAM, DILAMEG and AMELAF
(pharma companies associations orunions).
• CANIFARMA affiliate and member of 3 different subsections.
• All of our training workshops and diploma courses are officially certified by the STyPS(mexican
labor ministry).
• We are the creators of the INEFAM® National Health AccessConference.
• With over 200 alumni graduated, we are the creators of the Sales to Government and Institutional
Health Access diploma course (115 hrsduration).

6
INEFAM®: Which are our strenghts?

Percentage of clients that renew every

year with us: INEFAM® Portfolio Market audits: 34 60 Strategic intents for 2020: INEFAM® is actually the only
market audit provider that
Number of national and • doesn’t charge additional
92.7%
Medical devices.
Competitor’s Portfolio Market audits average: 3 international publications where • LATAM markets. fees for deliverables in
special formats.
we’ve participated

We have the best client service team in the pharma INEFAM:LATAM® Total Number of clients per year (all businesses branches)
market audits segment:
• Being an INEFAM Client Service Manager is a full career plan. 140
• They must have completed a full year working as an analyst for INEFAM.
• They must graduate successfully from the INEFAM® Sales to Government 120
and Market Institutional Access diploma course.
• They must have 50% Portuguese language domain. 100
• Their job profile states clearly that they have to be available to attend CS
requirements even on weekends & holidays.
80
60
INEFAM:LATAM® Income distribution by business branch. 40
20
10%
0
10% INEFAM
2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019

TRAINING
10% How strong are our competitors?
CONSULTING
INEFAM competitors Low Even though our level of expertise is very difficult to
Training compete with, we face new competitors every day.
ASSOCIATIONS 70% Medium

Consulting Competition helps us keep awake and our clients to have

High
a clearer scope on the capabilities of our business
Associations Low
portfolio.
 INEFAM:LATAM® Client base for 2019:

INEFAM® is actually the only market audit provider

that doesn’t charge additional fees for deliverables in
special formats.

Only market audit tools, clients with annual service contract.

México & LATAM

Pharmaceutical Public Sector
Audit Tools.

Specialized MarketAccess
Training.

Public Sector Business

Consulting.

Unions & Industrial Associations

Public Policies Guidance.
INEFAM:LATAM® PUBLIC MARKET
AUDIT TOOLS PORTFOLIO

9
INEFAM: Our Methodology.

2 Then, we filter, process, captureand

1 We process over 1,000 transparency & public accountability procedures per month validate all of the public procedures
(solicitudes de transparencia pública) in 7 different LATAM countries. obtained of about over 1,000 public
institutions in LATAM markets.

INEFAM is comprised of over 150 million unitary

3 records in a business intelligence datamart with a
size surpassing the 75 Gb.

10
INEFAM_LATAM® market audits portfolio.

12
INEFAM:MEX®

13
INEFAM:MEX®

Over 300 public institutions nationwide covered

month by month in INEFAM:MEX®

We measure drugs, medical devices and healing

material groups.

14
INEFAM:MEX® Audit Tools Specs (overall public market visibility:90%):
• INEFAM-EWS®
• Predictive model. Is a single view of a mix of all • INEFAM-ALTAS®
the other INEFAM:MEX® market udit tools to • Over 200 public institutions report in INEFAM:MEX® the product deliveries to their hospitals or warehouses.
predict the posible issues that any given
molecule can be experiencing in order to take
immediate action.
• INEFAM-CONSUMOS®
• Shows with an amazing level of detail the inventory indexes (CPM,
DPN, DMN, inventory days) used by IMSS, ISSSTE, CENSIDA, INCAN
& PEMEX to measure the real drug demand.

• INEFAM-LT® • Customized KPI’s:

• We report to all of our clients personalized • In order to measure the
daily reports of published bids and tenders in business performace of
order to take immediate business opportunity the pharma company’s
with over 300 mexican public institutions, teams, we develop
reporting an average of 5,000 tenders per customized KPI
year. dashboards for our
clients.

• INEFAM-RX® • INEFAM-STATS®
• INEFAM:FALLOS®
• A powerful BI tool developed to analyze in detail • Statistical data useful to
• Once the tender has been successfully
the prescriptions made by aprox 50,000 specialty know the details of the
assigned to a selected vendor, we present on
physicians in over 11 public institutions nationwide. Mexican sector, like
this business intelligence report the
sanitary registrations,
comprehensive tool for analyzing the contracts
referece prices, patent
that are to be accomplished during the year.
durations, hopsitals
sanitary certifications,
public sector physicians
directory, etc.

• INEFAM-SP®
• Once the contract has been assigned, the
public institution buyer starts paying to the • INEFAM-PAPS®
selected vendor. In México, by law, these • The only available public sector Audit to measure • New public sector audits:
contracts have to be executed minumum at a the medical devices and the healing materials • INEFAM-REPORDERS®.
40% range, so it’s important to keep track of purchased by over 100 public institutions in México. • IMSS TORRE DE CONTROL.
those contracts that are not moving fast to the • Federal/State Budget.
100% or 120%. • INEFAM:COMEXT.
INEFAM:MEX® Online samples, race bars.

1) Online sample: Race bar cumulative contracts and assignments per

manufacturer, units, 2015-2020. Source: INEFAM-FALLOS®

https://infogram.com/1pk6y6yqkkwwk2i9x0lk2ew337a39k2jz75?live

2) Online sample: Race bar cumulative contracts and assignments per

manufacturer, values in MXN, 2015-2020. Source: INEFAM-FALLOS®

https://infogram.com/1p20dnjvp569vju0vwzgg0wqrecrr9m7xp6?live

16
INEFAM:LATAM®

17
 INEFAM:LATAM-Marker®.

Within a single comprehensive report in a business intelligence

environment, the client can perform detailed research of any
given molecule in 7 different LATAM countries (México, Brazil,
Colombia, Guatemala, Panamá, República Dominicana & Costa
Rica), for units, values, manufacturers, sellers and institutions.

18
INEFAM:LATAM® Database Export Sample for Ranitidine:

Client can export data to perform market insights and comparisons for
simple and clear intercountry comparisons and market shares.

INEFAM:LATAM® allows queries based on drug definition,

country, institution/buyer, manufacturer, type of
purchase, among other (all these based on data
availability by the source).

19
INEFAM:BRA®

• INEFAM-BRA®:

• INEFAM-BRA. Over
1,300 MUSD per year in
the market audit tool.

• INEFAM-STATSBRASIL.
Prices, ex factory,
PMVG, ANVISA health
records issued.
INEFAM:BRA® monitors the drugs
and medicine purchases of 2,638
buyers all along the country.

20
INEFAM:COL®

• INEFAM-COL®:

• INEFAM-COL. Over 2,000 MUSD per year in the market audit tool.

• INEFAM-STATS COLOMBIA. Prices, INVIMA health records issued.

Total INEFAM:COL® monitors the expenditure of

drugs and medicine purchases of 535 nationwide
buyers.

21
INEFAM:CENTRAL AMERICA®

• INEFAM-GUATEMALA®:
• INEFAM-GUA.
• INEFAM-STATS GUA.

• INEFAM-PANAMÁ®:
• INEFAM-PAN.
• INEFAM-STATS GUA.

• INEFAM-COSTA RICA®:
• INEFAM-CR.
• INEFAM-STATS CR.

• INEFAM-REPÚBLICA DOMINICANA®:
• INEFAM-RD.
• INEFAM-STATS RD.

22
Please feel free to contact us!

José Carlos Ferreyra

[email protected]

Enrique Martínez M.
[email protected]

23